LightNews LightNews
banner
updates.chemo.org.uk
@updates.chemo.org.uk
10 followers 1 following 270 posts
Posts Replies Media Videos
updates.chemo.org.uk
🤖 Automated message

25 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-11-13.html

Changes: methotrexate, larotrectinib sulfate, methotrexate disodium, teclistamab, afatinib dimaleate, l...
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
November 13, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

6 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-11-10.html

Changes: dimethyl fumarate, ropeginterferon alfa-2b, cisplatin, elranatamab, methotrexate
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
November 10, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

6 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-11-06.html

Changes: fluorouracil, Ublituximab, fulvestrant, melphalan hydrochloride, dimethyl fumarate, ropeginterf...
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
November 6, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

5 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-11-03.html

Changes: teriflunomide, bevacizumab, fluorouracil, fulvestrant
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
November 3, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

4 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-10-30.html

Changes: pertuzumab, apalutamide, teriflunomide, bevacizumab
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
October 30, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

3 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-10-27.html

Changes: triptorelin acetate, pertuzumab, fluorouracil
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
October 27, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

NHS England has updated the Cancer Drugs Fund List to version 1.376.

https://updates.chemo.org.uk/news/CDFNews_1.376.html

Changes - 👇 🧵
NHS England updates CDF List – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
October 24, 2025 at 6:03 PM
updates.chemo.org.uk
🤖 Automated message

7 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-10-23.html

Changes: amivantamab, rituximab, nivolumab, triptorelin acetate, pertuzumab
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
October 23, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

5 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-10-20.html

Changes: Leniolisib phosphate, dimethyl fumarate, natalizumab, amivantamab
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
October 20, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

5 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-10-16.html

Changes: mycophenolate mofetil, trabectedin, Leniolisib phosphate, dimethyl fumarate
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
October 16, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

9 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-10-13.html

Changes: cytarabine, tivozanib hydrochloride monohydrate, eribulin, rituximab, mycophenolate mofetil, tr...
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
October 13, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

NHS England has updated the Cancer Drugs Fund List to version 1.375.

https://updates.chemo.org.uk/news/CDFNews_1.375.html

Changes - 👇 🧵
NHS England updates CDF List – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
October 9, 2025 at 6:02 PM
updates.chemo.org.uk
🤖 Automated message

5 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-10-09.html

Changes: nivolumab, atezolizumab, amivantamab, cytarabine
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
October 9, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

3 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-10-06.html

Changes: belimumab, nivolumab, tivozanib hydrochloride monohydrate
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
October 6, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

5 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-10-02.html

Changes: cabozantinib, selpercatinib, belimumab, nivolumab
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
October 2, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

6 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-09-29.html

Changes: fingolimod hydrochloride, anastrozole, cabozantinib, belimumab
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
September 29, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

3 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-09-25.html

Changes: hydroxycarbamide, fingolimod hydrochloride, belimumab
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
September 25, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

5 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-09-22.html

Changes: dabrafenib mesilate, Idecabtagene vicleucel, niraparib tosylate monohydrate, hydroxycarbamide
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
September 22, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

NHS England has updated the Cancer Drugs Fund List to version 1.374.

https://updates.chemo.org.uk/news/CDFNews_1.374.html

Changes - 👇 🧵
NHS England updates CDF List – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
September 19, 2025 at 6:01 PM
updates.chemo.org.uk
🤖 Automated message

7 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-09-18.html

Changes: bleomycin sulfate, belimumab, amivantamab, dabrafenib mesilate, Idecabtagene vicleucel
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
September 18, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

10 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-09-15.html

Changes: ruxolitinib phosphate, pomalidomide, bleomycin sulfate, amivantamab
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
September 15, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

14 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-09-11.html

Changes: apalutamide, teriflunomide, pemetrexed disodium, Bosutinib, acalabrutinib maleate, cetuximab, ...
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
September 11, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

CRUK/UK SACT Board have updated consent forms.

https://www.cancerresearchuk.org/health-professional/treatment-and-other-post-diagnosis-issues/consent-forms-for-sact-systemic-anti-cancer-therapy

Changes: Supportive medicines - reviewed and updated
Consent forms for SACT (Systemic Anti-Cancer Therapy)
Standardised SACT regimen-specific consent forms for Clinicians and healthcare professionals involved with consenting and treating patients with SACT.
www.cancerresearchuk.org
September 8, 2025 at 4:40 PM
updates.chemo.org.uk
🤖 Automated message

7 cancer treatment summary of product characteristics have been updated recently.

https://updates.chemo.org.uk/news/SPC_updates_2025-09-08.html

Changes: axicabtagene ciloleucel, atezolizumab, nivolumab, apalutamide, pemetrexed disodium
Updated Summary of Product Characteristics – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
September 8, 2025 at 3:23 PM
updates.chemo.org.uk
🤖 Automated message

NHS England has updated the Cancer Drugs Fund List to version 1.373.

https://updates.chemo.org.uk/news/CDFNews_1.373.html

Changes - 👇 🧵
NHS England updates CDF List – Chemotherapy Updates
Providing automated updates about changes to chemotherapy commissioning, consent, and licenses.
updates.chemo.org.uk
September 5, 2025 at 9:02 AM